Assay validation for KIM-1: human urinary renal dysfunction biomarker

Area of Science:

• Biomarker Discovery and Validation
• Renal Physiology and Pathology
• Drug Development and Toxicology

Background:

• Urinary Kidney Injury Molecule-1 (KIM-1) is a key biomarker for detecting kidney tubular injury.
• Early and accurate detection of kidney injury is crucial in clinical settings and drug development.
• Non-invasive biomarkers are highly desirable for routine monitoring and high-throughput screening.

Purpose of the Study:

• To analytically validate a quantitative assay for urinary KIM-1.
• To establish the reliability and performance characteristics of the KIM-1 assay.
• To confirm the utility of urinary KIM-1 as a biomarker for early kidney injury.

Main Methods:

• Development of an Enzyme-Linked Immunosorbent Assay (ELISA) using Duo-set reagents.
• Validation of assay parameters including linearity, precision, limit of quantification, recovery, and stability.
• Determination of reference ranges and upper limit of quantitation for healthy and patient populations.

Main Results:

• The assay demonstrated robustness across all validated parameters.
• Established reference range for healthy individuals: 59 - 2146 pg/mL.
• Determined upper limit of quantitation for patient samples: 17168 pg/mL.

Conclusions:

• The validated assay is a robust, sensitive, and reproducible method for quantifying urinary KIM-1.
• This non-invasive assay facilitates early detection of kidney injury in drug development.
• Urinary KIM-1 measurement offers a potentially high-throughput approach for renal safety assessment.